Education
About Us
Working with TipRanks
Follow Us
Bayer (BAYRY)
OTHER OTC:BAYRY
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.52Last Year’s EPS
0.76Same Quarter Last Year
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 05, 2025
|% Change Since: -4.52%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Neutral
The earnings call reflected a mixed sentiment with strong performance in Pharmaceuticals and Consumer Health segments, driven by strategic innovation and operational efficiency. However, this was offset by significant challenges in the Crop Science division and ongoing regulatory and litigation issues, leading to a cautious outlook for 2025.Company Guidance
In the Q3 2024 earnings call for BAYN.DE, the company provided detailed guidance and insights into their performance metrics. They expect to meet full-year targets for sales growth, core earnings per share, and free cash flow, despite a forecasted 2% decline in the agriculture market. Pharmaceuticals is performing well, with sales projected at the upper end of upgraded guidance owing to the success of products like Nubeqa and Kerendia. Consumer Health is growing, though not as rapidly as anticipated due to market slowdowns in the U.S. and China, and Crop Science is facing challenges from regulatory and pricing pressures. Clean EBITDA is expected to be lower, but the company is focused on optimizing P&L, managing costs, and strengthening innovation pipelines, particularly with upcoming launches like Precision Smart Corn in 2027. For 2025, they anticipate a cautious market environment with potential regulatory impacts, but remain committed to operational efficiency and strategic innovation to drive future growth.Pharmaceuticals Success
Pharmaceuticals sales are up, with expectations to deliver at the upper end of upgraded guidance in both sales and earnings. Nubeqa reached blockbuster status with a growth of 83% and Kerendia sales nearly doubled.
Consumer Health Growth
Consumer Health achieved a 6% year-over-year sales growth, reaching EUR 1.4 billion, with a clean EBITDA margin improvement to 25.5%, a 330 basis point increase year-over-year.
Dynamic Shared Ownership Model
The new operating model has led to a reduction of 5,500 jobs, primarily managerial, improving operational efficiency and cash flow.
Innovative Agricultural Products
Launch of Precion Smart Corn in multiple countries, with plans for a biotech version in 2027. Farmers have reported significant yield improvements and resistance to environmental challenges.
Strategic Focus on Innovation
10 blockbusters planned for launch over the next 10 years, including new insecticides and herbicides to enhance competitive differentiation.
---
BAYRY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
BAYRY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 05, 2025 | $6.19 | $6.59 | +6.46% |
| Nov 12, 2024 | $6.50 | $5.54 | -14.77% |
| Aug 06, 2024 | $7.40 | $6.92 | -6.49% |
| May 14, 2024 | $7.94 | $7.91 | -0.38% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Bayer (BAYRY) report earnings?
Bayer (BAYRY) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is Bayer (BAYRY) earnings time?
Bayer (BAYRY) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BAYRY EPS forecast?
BAYRY EPS forecast for the fiscal quarter 2025 (Q1) is 0.52.
---